Breast cancer predictive value of tests. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Axilla Mammary Glands, Human Lymph Nodes Nipples Neoplastic Stem Cells Neoplastic Cells, Circulating Epithelial Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases45

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Metastasis Neoplasm Invasiveness Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Carcinoma Lymphatic Metastasis Ovarian Neoplasms Neoplasm Recurrence, Local Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Disease Progression Lung Neoplasms Fibrocystic Breast Disease Neoplasms Prostatic Neoplasms Bone Neoplasms Colonic Neoplasms Carcinoma, Ductal Carcinoma in Situ Stomach Neoplasms Neoplasms, Second Primary Cell Transformation, Neoplastic Adenocarcinoma Triple Negative Breast Neoplasms Uterine Cervical Neoplasms Inflammatory Breast Neoplasms Pancreatic Neoplasms Fibroadenoma Colorectal Neoplasms Neoplastic Cells, Circulating Neovascularization, Pathologic Endometrial Neoplasms Neoplasms, Basal Cell Carcinoma, Squamous Cell Carcinoma, Non-Small-Cell Lung Neoplasms, Radiation-Induced Urinary Bladder Neoplasms Neoplasms, Multiple Primary Mammary Neoplasms, Animal Precancerous Conditions

Chemicals and Drugs53

Receptors, Estrogen Receptor, erbB-2 Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens BRCA2 Protein BRCA1 Protein RNA, Messenger Aromatase Inhibitors Estrogen Antagonists DNA, Neoplasm Fluorouracil Estradiol Cyclophosphamide RNA, Small Interfering Antibodies, Monoclonal, Humanized Epirubicin Estrogen Receptor Modulators Tumor Suppressor Protein p53 Antibodies, Monoclonal Selective Estrogen Receptor Modulators Nitriles Ki-67 Antigen Receptor, Epidermal Growth Factor Paclitaxel Antigens, Neoplasm Tumor Suppressor Proteins RNA, Neoplasm Cancer Vaccines Triazoles Mucin-1 Anticarcinogenic Agents Radiopharmaceuticals Antigens, CD24 Anthracyclines Transcription Factors Biological Markers Antibiotics, Antineoplastic MicroRNAs DNA-Binding Proteins Doxorubicin Proto-Oncogene Proteins c-akt Methotrexate Proto-Oncogene Proteins Nuclear Proteins Cyclin D1 Cisplatin Deoxycytidine

Analytical, Diagnostic and Therapeutic Techniques and Equipment82

Predictive Value of Tests Sensitivity and Specificity Prognosis Mammography Risk Factors Neoplasm Staging Prospective Studies Early Detection of Cancer Mastectomy Chemotherapy, Adjuvant Retrospective Studies Follow-Up Studies Survival Analysis Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Risk Assessment Disease-Free Survival Reproducibility of Results Risk Immunohistochemistry Gene Expression Profiling Survival Rate Treatment Outcome Breast Self-Examination Mammary Neoplasms, Experimental Cohort Studies Reverse Transcriptase Polymerase Chain Reaction Odds Ratio Incidence ROC Curve Multivariate Analysis Mastectomy, Segmental Mass Screening Ultrasonography, Mammary Logistic Models Registries Blotting, Western Xenograft Model Antitumor Assays Kaplan-Meier Estimate Questionnaires Polymerase Chain Reaction Oligonucleotide Array Sequence Analysis False Positive Reactions False Negative Reactions Neoplasm Transplantation Biopsy Transplantation, Heterologous Immunoenzyme Techniques Tissue Array Analysis Tumor Burden Combined Modality Therapy Confidence Intervals SEER Program Biopsy, Needle Neoplasm Grading Proportional Hazards Models Breast Implants Neoadjuvant Therapy Radiotherapy, Adjuvant Genetic Testing Transfection Clinical Trials as Topic Sentinel Lymph Node Biopsy Mammaplasty Drug Screening Assays, Antitumor Drug Administration Schedule Tomography, X-Ray Computed Lymph Node Excision Radiotherapy In Situ Hybridization, Fluorescence Molecular Targeted Therapy Estrogen Replacement Therapy Enzyme-Linked Immunosorbent Assay Gene Knockdown Techniques Regression Analysis Pilot Projects Models, Biological Probability Positron-Emission Tomography Chi-Square Distribution DNA Mutational Analysis Mastectomy, Radical

Psychiatry and Psychology3

Breast Feeding Breast Self-Examination Smoking

Phenomena and Processes52

Sensitivity and Specificity Gene Expression Regulation, Neoplastic Genes, BRCA1 Postmenopause Genetic Predisposition to Disease Breast Feeding Premenopause Drug Resistance, Neoplasm Risk Cell Proliferation Menopause Time Factors Odds Ratio Genes, BRCA2 Genes, erbB-2 Mutation Apoptosis Signal Transduction Genotype Cell Movement Cell Division Germ-Line Mutation Polymorphism, Genetic Down-Regulation Gene Amplification DNA Methylation Promoter Regions, Genetic Cell Growth Processes Dose-Response Relationship, Drug Transfection Cell Cycle Parity RNA Interference Up-Regulation Gene Expression Phenotype Gene Silencing Genes, Neoplasm Cell Survival Algorithms Base Sequence Genes, Tumor Suppressor Pregnancy Phosphorylation Genes, p53 Alleles Epithelial-Mesenchymal Transition Probability Chi-Square Distribution Heterozygote Diet Polymorphism, Single Nucleotide

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life National Cancer Institute (U.S.)Age Distribution

Humanities1

Quality of Life

Information Science8

Survival Rate Incidence Registries Questionnaires SEER Program Algorithms Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care38

Predictive Value of Tests Sensitivity and Specificity Risk Factors Prospective Studies Retrospective Studies Follow-Up Studies Survival Analysis Case-Control Studies Risk Assessment Disease-Free Survival Reproducibility of Results Risk Survival Rate Treatment Outcome Cohort Studies Age Factors Odds Ratio Incidence ROC Curve Multivariate Analysis Mass Screening Logistic Models Registries Kaplan-Meier Estimate Questionnaires Confidence Intervals SEER Program Proportional Hazards Models Genetic Testing Clinical Trials as Topic Parity Regression Analysis Pilot Projects Probability Chi-Square Distribution National Cancer Institute (U.S.)Age of Onset Age Distribution

Geographicals3

United States China Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Breast Predictive Value of Tests Breast Neoplasms Carcinoma, Ductal, Breast Receptors, Estrogen Sensitivity and Specificity Breast Diseases Cell Line, Tumor Receptor, erbB-2 Prognosis Tamoxifen Receptors, Progesterone Mammography Gene Expression Regulation, Neoplastic Neoplasm Metastasis Tumor Markers, Biological Neoplasm Invasiveness Risk Factors Neoplasm Staging Breast Neoplasms, Male Prospective Studies Antineoplastic Agents, Hormonal Early Detection of Cancer Mastectomy Antineoplastic Agents Neoplasm Proteins Genes, BRCA1 Chemotherapy, Adjuvant Retrospective Studies Postmenopause Carcinoma, Lobular Follow-Up Studies Survival Analysis Case-Control Studies Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Antineoplastic Combined Chemotherapy Protocols MCF-7 Cells Carcinoma Lymphatic Metastasis Mice, Nude Risk Assessment Disease-Free Survival Breast Feeding Premenopause Drug Resistance, Neoplasm Reproducibility of Results Tumor Cells, Cultured Risk Immunohistochemistry Estrogen Receptor alpha Ovarian Neoplasms Neoplasm Recurrence, Local Estrogens Gene Expression Profiling Survival Rate Treatment Outcome Breast Self-Examination Mammary Neoplasms, Experimental Neoplasms, Hormone-Dependent Cell Proliferation Menopause Cohort Studies Age Factors Disease Progression Reverse Transcriptase Polymerase Chain Reaction Lung Neoplasms Time Factors BRCA2 Protein Odds Ratio Incidence BRCA1 Protein Genes, BRCA2 RNA, Messenger ROC Curve Multivariate Analysis Axilla Fibrocystic Breast Disease Aromatase Inhibitors Neoplasms Estrogen Antagonists Genes, erbB-2 Prostatic Neoplasms Survivors Mastectomy, Segmental Mass Screening Mammary Glands, Human DNA, Neoplasm Ultrasonography, Mammary Mutation United States Logistic Models Registries Fluorouracil Blotting, Western Bone Neoplasms Xenograft Model Antitumor Assays Estradiol Kaplan-Meier Estimate Apoptosis

No FAQ available that match "breast cancer predictive value of tests"